MetaCap

Coya Therapeutics Insider Trades

NASDAQ: COYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.95-0.03 (-1.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Coya Therapeutics insider activity

No Coya Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows GOLDSTEIN DOV A MD (Director) reporting a transaction in 17,557 shares at $1.09 on Aug 18, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put COYA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

COYA insider transactions

Coya Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 18, 2025GOLDSTEIN DOV A MDDirectorOption exercise17,557$19.14KForm 4
Nov 14, 2024SNYDER DAVID SChief Financial OfficerBuy1,800$12.93KForm 4
Nov 13, 2024Swaminathan ArunChief Executive OfficerBuy5,000$36.80KForm 4
Nov 11, 2024Swaminathan ArunChief Executive OfficerBuy5,000$36.69KForm 4
Nov 11, 2024Grossman FredChief Medical OfficerBuy2,710$19.97KForm 4
Aug 22, 2023Lee AnnDirectorBuy1,000$3.62KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related